3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate
C24H23N3O4S — CID 159764789
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate
3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate (PubChem CID 159764789) has the molecular formula C24H23N3O4S and a molecular weight of 449.53 g/mol. Its IUPAC name is 3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate.
Molecular Properties
| Compound Name | 3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate |
|---|---|
| PubChem CID | 159764789 |
| Molecular Formula | C24H23N3O4S |
| Molecular Weight | 449.53 g/mol |
| Exact Mass | 449.14 |
| IUPAC Name | 3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazol-8-ylmethyl 2-[2-(2-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]acetate |
| SMILES | COc1ccccc1-c1nc(C)c(CC(=O)OCc2ccc3c(c2)nc2n3CCOC2)s1 |
| InChI | InChI=1S/C24H23N3O4S/c1-15-21(32-24(25-15)17-5-3-4-6-20(17)29-2)12-23(28)31-13-16-7-8-19-18(11-16)26-22-14-30-10-9-27(19)22/h3-8,11H,9-10,12-14H2,1-2H3 |
| InChIKey | NFIYSJHGDSYAMG-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 75.47 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.53 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159764789 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.